Evaluation of the effectiveness of a predictive model to restore fertility in premature reduction of ovarian reserve in programmes of assisted reproductive technologies
https://doi.org/10.25694/URMJ.2018.13.43
Abstract
Ovarian reserve - the functional state of the reproductive system, the full value of which provides growth, maturation of the follicle, maturation of the oocyte in the dominant follicle, ovulation and fertilization of a full egg. A full ovarian reserve in assisted reproductive technology (art) programs provides an adequate ovarian response to the introduction of ovulation inducers and determines the success of such programs [4,5] Today, there are several ways to determine the biological and functional age of the ovaries. These methods help to predict the outcomes of infertility treatment by the method of assisted reproductive technologies (art). The development of a predictive model of fertility recovery in women with infertility due to premature depletion of ovarian reserve, based on the study of their molecular genetic and hormonal characteristics will improve the effectiveness of assisted reproductive technology programs.
About the Authors
V. V. Kovalev
ФГБОУ ВО «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Russian Federation
Russian Federation
N. V. Melnikova
МЦ «УГМК-Здоровье»
Russian Federation
Russian Federation
References
1. Назаренко Т.А., Мишеева Н.Г. Бесплодие и возраст: пути решения проблемы. М.: МЕДпрессинформ,, 2010. 208с.
2. Боярский К.Ю. Роль показателей овариального резерва при лечении бесплодия методом ЭКО и ПЭ/В кн.: Лечение женского и мужского бесплодия, спомагательные репродуктивные технологии. Под ред. B.И. Кулакова, Б.В. Леонова, Л.Н. Кузьмичева. М.: МИА, 2005. С. 53-61.)
3. Кравченко Е.Н., Кривчик Г.В., Макаркина Л.Г. И др. Диагностика и лечение бесплодия. Омск: Издательство «ЮНЗ». 2012. 89 с.)
4. Краснопольская К.В., Назаренко Т.А. Клинические аспекты ведения бесплодия в браке. М.: ГЭОТАР -Медиа, 2013. 327с.)
5. Назаренко Т.А. Стимуляция функции яичников. 5-е изд., доп. и перераб. М.: МЕД пресс-информ, 2015. 288 с.)
6. Волков Н.И. Тактика ведения пациенток с миомой матки в клинике женского бесплодия. В кн.: Бесплодный брак. Современные подходы к диагностике и лечению: руководство. Под. Ред. Г.И. Сухих, Т.А. Назаренко. 2-е изд. М.: ГЕОТАР - МЕДИА -2010. С 468-463.
7. Бебия З.Н. Новый взгляд на патогенез синдрома поликистозных яичников // Бебия З.Н., Гаджиева Т.С. Новые подходы к решению проблем женского здоровья. - Спб.: СПБМАПО 2000. - с. 11 - 18.
8. Бебия З.Н., Орлов В.М. антимюллеровый фактор // Ж. акуш. и жен. Болезн. - 1999. - № 2. - с. 66-70.
9. Назаренко Т. А., Мишиева Н. Г., Фанченко Н. Д. Роль антимюллерова гормона в оценке овариального резерва // Проблемы репродукции. - 2002. - Т. 8, № 3. - C. 36-43.
10. Teixeira J., Maheswaran S., Donahoe P.K. Mullerian inhibiting substance: an instructive development hormone wish diadnostic applications Endocr. Rev. -2001. - Vol. 22. -P. 657-674.
11. - Deffiern Х., Antoine J. M. Inhibins, activins and anti-Mullerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine Gynecol. Obstet. Fertil. - 2003. -Vol. 31, № 11. - P. 900-911.
12. - Early follicular serum mullerian-ingibiting substance levels are associated with ovarian response during assisted predictive technology cycles Seifer D. B. [et al.] Fertil. Steril/- 2002/- Vol/ 77/ - P/468-471
13. - Inhibin B and anti-Mullerian hormone: markers of ovarian respons in IVFICSI patients Muttukrishna S. [et aI.] BJOG. - 2004. - Vol. 111 - P. 1248-1253 - 43?
14. - High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status Fachin R. [et. al.] Hum. Reprod. - 2005. -Vol. 20/ - P. 923-92
15. - Anti-Millerian hormone as a predictor of IVF outcome Lecamge D. N. [et aI.] Reprod. Biomed. Online. - 2007. - Vol. 14, № 5. - P. 602-610.
16. - Evaluation of Mullerian hormone as a test for the prediction of ovarian reserveKwee J. [et. al.] Fertil. Steril. - 2008. - Vol. 90 № 3. P. 737 - 743
17. - Undetectable serum Anti-Millerian hormone levels and occurrence of ongoing pregnancy Fraisse T. [et. al.] Fertil. Steril. - 2008. - Vol. 89 № 3. P. 723
18. Anti-Millerian hormone -based approach to controlled ovarian stimulasian for assisted coseptionNelson S. M. [et. al.] Hum. Reprod. - 2009. - Vol. 24 - P. 867-875
19. - Марченко Л.А., Залетаев Д.В. Генетическая гетерогенность преждевременного истощения яичников и наследственные факторы ранней менопаузы. Пробл. репрод 2007; 1: 6-12.
20. - Марченко Л.А., Залетаев Д.В. Генетическая гетерогенность преждевременного истощения яичников и наследственные факторы ранней менопаузы. Пробл. репрод 2007; 1: 6-12.
21. Marozzi A., Vegetti W., Manfredini E. et al. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000; 15: 197-202.
22. Sherman S.L. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000; 97: 189- 194.
23. Hagerman R.J., Leavitt B.R., Farzin F. et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004; 74: 1051-1056.
24. - Hagerman R.J., Hagerman P.J. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 2002; 12: 278-283.
25. Kaufman F.R., Kogut M.D., Donnell G.N. et al. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994- 998.
26. Crisponi L., Deiana M., Loi A. et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001; 27: 159-166.
27. Bodega B., Porta C., Crosignani P.G. et al. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod 2004; 10: 555-557.
28. De Baere E., Dixon M.J., Small K.W. et al. Spectrum of FOXL2 gene mutations in blepharophimo-sis-ptosisepicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 2001; 10: 1591-1600.
29. Fogli A., Rodriguez D., Eymard-Pierre E. et al. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 2003; 72: 1544- 1550.
30. Di Pasquale E., Beck-Peccoz P., Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75: 106-111.
31. Ahonen P., Myllarniemi S., Sipila I. et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829- 1836.
32. Nagamine K., Peterson P., Scott H.S. et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398.
33. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 1997; 17: 399-403.
34. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocrinol Rev 1997; 18: 107-134.
35. Bakalov V.K., Vanderhoof V.H., Bondy C.A. et al. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency young women with spontaneous premature ovarian failure. Hum Reprod 2002; 17: 2096-2100. 883-890.
Review
For citations:
Kovalev VV, Melnikova NV. Evaluation of the effectiveness of a predictive model to restore fertility in premature reduction of ovarian reserve in programmes of assisted reproductive technologies. Ural Medical Journal. 2018;(13):28-32. (In Russ.) https://doi.org/10.25694/URMJ.2018.13.43
Views:
122
Email this article 